Anzeige
Mehr »
Login
Mittwoch, 24.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
29 Leser
Artikel bewerten:
(0)

Global Array Instruments Market 2015-2019 - Advances in Personalized Medicines with Affymetrix, Agilent Technologies & Illumina Dominating

DUBLIN, June 24, 2015 /PRNewswire/ --

Research and Markets(http://www.researchandmarkets.com/research/54fkmt/global_array) has announced the addition of the "Global Array Instruments Market 2015-2019" report to their offering.

600769

The global array instruments market to grow at a CAGR of 12.48 % over the period 2014-2019

The global array instruments market can be divided into three segments: DNA microarrays, protein microarrays, and others including tissue microarrays and cell microarrays. This report covers the present scenario and the growth prospects of the global array instruments market for the period 2015-2019. To calculate the market size, the report considers revenue generated from sales of three applications used by life sciences companies, R&D institutes, and diagnostic laboratories.

Sophisticated technologies and tools such as NGS and microarray platforms enable rapid, large-scale, quantitative assessments of molecular and cellular biology procedures. Important discoveries in the biomedical field through the use of DNA and protein microarrays have already been implemented in clinical diagnostics, especially in oncology where they have had a broader impact. Genomic testing technologies to identify oncogenic variants and their response to specific drugs are widely used to develop personalized medicines. These advances enable both the generation and analysis of big data in applied life sciences research and basic information transfer during drug development.

According to the report, advances in the technology and sophistication of instruments used in healthcare have increased the demand for array instruments. Novel microarrays have been developed that can advance the fields of cell biology, genetics, and molecular biology and accelerate drug discovery processes. The design of fiber-optic microarrays and the merging of microarrays with microfluidics for bioassays are some new developments in the market. For instance, BioArray Solutions, Illumina, and Tm Bioscience are developing different types of array, such as bead-based arrays, to perform tests and make diagnoses.

Further, the report states that lack of skilled technicians and inadequate data management is hindering the market growth.

Key vendors

  • Affymetrix
  • Agilent Technologies
  • Illumina

Key Topics Covered:

  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Market Research Methodology
  5. Introduction
  6. Market Landscape
  7. Reimbursement and Coverage
  8. Market Segmentation by Application
  9. Geographical Segmentation
  10. Buying Criteria
  11. Market Growth Drivers
  12. Drivers and Their Impact
  13. Market Challenges
  14. Impact of Drivers and Challenges
  15. Market Trends
  16. Trends and Their Impact
  17. Vendor Landscape
  18. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/54fkmt/global_array

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.